Release details

2016-01-06 17:43 CET
  • Print
  • Share Share
en

CORRECTION: Mandatory Notification of Trade

This is a correction of the announcement from 16:06 06.01.2016 CET. Reason for the correction: Dates missing

Gitte Jensen Wegge, Vice President Operations at Vistin Pharma ASA, and a primary insider, has on 6 January sold 4,100 shares in Vistin Pharma at an average sales price of NOK 20.20 per share. Gitte Jensen Wegge also sold 200 shares on 5 January, at an average sales price of NOK 21.40 per share, and sold 700 shares on 4 January, at an average sales price of NOK 21.50 per share. Following these sales, Gitte Jensen Wegge holds 5,000 shares in Vistin Pharma.

HUG#1977127